Humana Inc. (NYSE:HUM) Announces Quarterly Dividend of $0.89

Humana Inc. (NYSE:HUM) declared a quarterly dividend on Thursday, April 17th, RTT News reports. Shareholders of record on Friday, June 27th will be given a dividend of 0.885 per share by the insurance provider on Friday, July 25th. This represents a $3.54 dividend on an annualized basis and a yield of 1.34%.

Humana has increased its dividend by an average of 8.1% annually over the last three years. Humana has a dividend payout ratio of 25.3% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Humana to earn $13.13 per share next year, which means the company should continue to be able to cover its $3.54 annual dividend with an expected future payout ratio of 27.0%.

Humana Trading Down 7.4 %

HUM opened at $264.41 on Friday. The company has a market cap of $31.91 billion, a P/E ratio of 26.57, a PEG ratio of 2.05 and a beta of 0.62. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The company’s 50 day moving average is $265.75 and its 200-day moving average is $269.97. Humana has a 1-year low of $213.31 and a 1-year high of $406.46.

Humana (NYSE:HUM) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities research analysts predict that Humana will post 16.47 earnings per share for the current fiscal year.

Analysts Set New Price Targets

HUM has been the topic of a number of research reports. Barclays boosted their price objective on Humana from $270.00 to $322.00 and gave the stock an “equal weight” rating in a research report on Friday, April 11th. Morgan Stanley lowered their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 12th. JPMorgan Chase & Co. cut their target price on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 18th. Guggenheim started coverage on shares of Humana in a research note on Wednesday, April 9th. They set a “buy” rating and a $326.00 price target for the company. Finally, StockNews.com raised Humana from a “hold” rating to a “buy” rating in a report on Monday, April 7th. Seventeen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $284.90.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Humana stock. Revolve Wealth Partners LLC acquired a new position in Humana Inc. (NYSE:HUM) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 798 shares of the insurance provider’s stock, valued at approximately $202,000. 92.38% of the stock is currently owned by institutional investors.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.